Medicare Enrolled

Dr. Lily Hwang, MD

Internal Medicine · Roswell, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1357 HEMBREE RD STE 200, Roswell, GA 30076
7709533331
In practice since 2008 (18 years)
NPI: 1669648986 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hwang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hwang? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hwang

Dr. Lily Hwang is an internal medicine specialist in Roswell, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Hwang performed 7,291 Medicare services across 393 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hwang received a total of $105,498 from 42 pharmaceutical and/or device companies across 582 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hwang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 4% volume in GA $105,498 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,291
Medicare services
Top 4% in GA for internal medicine
393
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~405 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Omalizumab injection (Xolair) for asthma/allergy 4,335 $30 $143
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
1,042 $3 $18
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
669 $8 $48
Allergen injection administration
Professional service for the administration of a single allergen injection.
227 $7 $42
Remote patient monitoring management, 20 min/month
Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month.
213 $37 $150
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
198 $59 $404
Remote vital sign monitoring management, each additional 20 minutes
This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period.
152 $31 $125
Remote patient monitoring device, 30 days
Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period.
121 $37 $180
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
89 $59 $180
Skin allergy test
A test where small amounts of potential allergens are injected into the skin to check for allergic reactions.
83 $6 $34
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
71 $20 $132
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
39 $13 $75
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
31 $122 $446
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $94 $296
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$105,498
Total received (2018-2024)
Avg $15,071/year across 7 years
Top 1% in GA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
582
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$89,661 (85.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,047 (8.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,789 (6.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$25,983
2023
$18,856
2022
$4,907
2021
$1,468
2020
$1,316
2019
$22,854
2018
$30,114

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$21,819
Grifols USA, LLC
$2,620
GENZYME CORPORATION
$429
Takeda Pharmaceuticals U.S.A., Inc.
$283
GlaxoSmithKline, LLC.
$224
Regeneron Healthcare Solutions, Inc.
$178
Blueprint Medicines Corporation
$132
Amgen Inc.
$76
CSL Behring
$70
PFIZER INC.
$45
ADMA BioManufacturing LLC
$44
Pharming Healthcare, Inc.
$29
Optinose US, Inc.
$21
BioCryst US Sales Co., LLC
$13
Top 3 companies account for 95.7% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$50,819
AstraZeneca Pharmaceuticals LP
$39,534
Genentech, Inc.
$4,125
Grifols USA, LLC
$2,639
GlaxoSmithKline, LLC.
$1,327
GENZYME CORPORATION
$990
Regeneron Healthcare Solutions, Inc.
$637
Takeda Pharmaceuticals U.S.A., Inc.
$608
Teva Pharmaceuticals USA, Inc.
$520
CSL Behring
$494
Novartis Pharmaceuticals Corporation
$472
Genentech USA, Inc.
$399
Amgen Inc.
$362
Covis Pharma GmBH
$290
Shire North American Group Inc
$231
BioCryst US Sales Co., LLC
$214
Pharming Healthcare, Inc.
$199
Boehringer Ingelheim Pharmaceuticals, Inc.
$192
ALK-Abello, Inc
$156
Blueprint Medicines Corporation
$132
Kaleo, Inc.
$116
Circassia Pharmaceuticals Inc
$104
SANOFI-AVENTIS U.S. LLC
$102
Dermavant Sciences, Inc.
$96
OptiNose US, Inc.
$86
Covis Pharma B.V.
$82
ABBVIE INC.
$67
Octapharma USA, Inc.
$64
kaleo, Inc.
$63
Covis Pharma GmbH
$58
Jubilant HollisterStier LLC
$57
ADMA BioManufacturing LLC
$44
LEO Pharma Inc.
$35
Sunovion Pharmaceuticals Inc.
$35
Optinose US, Inc.
$33
Horizon Therapeutics plc
$19
Hikma Pharmaceuticals USA
$19
Encore Dermatology Inc.
$18
Merck Sharp & Dohme Corporation
$17
Avadel Pharmaceuticals (USA), Inc.
$16
Mylan Specialty L.P.
$14
Incyte Corporation
$14
Top 3 companies account for 89.6% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · ADBRY · AIRSUPRA · ALVESCO · AUVI-Q · AYVAKIT · AirDuo Digihaler · Auvi-Q · BREO · BREZTRI · CINQAIR · CUTAQUIG · CUVITRU · DERMATITIS - DISEASE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EUCRISA · FASENRA · FIRAZYR · Grastek · HYQVIA · Haegarda · Hizentra · Impoyz · Karbinal ER · LONHALA MAGNAIR · NIOX VERO · NUCALA · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Odactra · Orladeyo · PANZYGA · PRE-PEN · ProAir Digihaler · QVAR · RINVOQ · RUCONEST · Ryaltris · SHINGRIX · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · VTAMA · XALKORI · XOLAIR · Xembify · Xhance · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for internal medicine in GA.

Looking for an internal medicine specialist in Roswell?
Compare internal medicine physicians in the Roswell area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
2,144
Per 100K population
200.7
County median income
$91,490
Nearest hospital
WELLSTAR NORTH FULTON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hwang is a mixed practice specialist, with above-average Medicare volume (top 4% in GA), with speaking/promotional industry engagement in the top 1% of GA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hwang experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Hwang performed 4,335 omalizumab injection (xolair) for asthma/allergy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hwang receive payments from pharmaceutical companies?
Yes. Dr. Hwang received a total of $105,498 from 42 companies across 582 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hwang's costs compare to other internal medicine physicians in Roswell?
Dr. Hwang's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hwang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →